Chemometec receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
ChemoMetec A/S (CHEMM)
ChemoMetec A/S stock price live, this page displays CSE CHEMM stock exchange data. View the CHEMM premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the ChemoMetec A/S real time stock price chart below.
What Is the ChemoMetec A/S Stock Price Today?
The ChemoMetec A/S stock price today is 510.00.
What Is the Stock Symbol for ChemoMetec A/S?
The stock ticker symbol for ChemoMetec A/S is CHEMM.
Is CHEMM the Same as $CHEMM?
$CHEMM is a common way to refer to the ChemoMetec A/S ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does ChemoMetec A/S Trade On?
ChemoMetec A/S is listed and trades on the Copenhagen stock exchange.
Is ChemoMetec A/S a Good Stock to Buy?
Determining whether ChemoMetec A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current ChemoMetec A/S share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CHEMM quote. (ISIN: DK0060055861)
What Is the ChemoMetec A/S Stock Price Today?
The ChemoMetec A/S stock price today is 510.00.
What Is the Stock Symbol for ChemoMetec A/S?
The stock ticker symbol for ChemoMetec A/S is CHEMM.
Is CHEMM the Same as $CHEMM?
$CHEMM is a common way to refer to the ChemoMetec A/S ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does ChemoMetec A/S Trade On?
ChemoMetec A/S is listed and trades on the Copenhagen stock exchange.
Is ChemoMetec A/S a Good Stock to Buy?
Determining whether ChemoMetec A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current ChemoMetec A/S share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CHEMM quote. (ISIN: DK0060055861)
510.00
-11.50(-2.21%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
504.00
526.50
52 wk Range
235.20
804.00
CHEMM is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
504.00526.50
52 wk Range
235.20804.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.40%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.40%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CHEMM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
635.00
Upside
+24.51%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Chemometec receives Investment Bank Analyst Rating Update- Investing.com
Pro
- Chemometec receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Chemometec receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Chemometec receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Strong Sell
Moving Averages
Neutral
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 635.00
(+24.51% Upside)
ChemoMetec A/S Earnings Call Summary for Q4/2026
- ChemoMetec Q4 EPS of -$1.15 missed estimates of -$0.80 by 44%; revenue of $124M slightly beat forecasts at $123.33M; shares fell 6.22% to $490.
- Full-year revenue hit record DKK 511M, up 7% at constant FX; EBITDA margin expanded to 55.0% from 52.1%; XcytoMatic sales surged 146% YoY to DKK 68.1M.
- FY 2026/2027 guidance set at DKK 545-575M revenue and DKK 300-313M EBITDA; excludes uncertain Roche, Tecan, Hamilton partnership revenue contributions.
- Management adopted conservative forecasting after prior miss; expects XcytoMatic to become lead instrument by next year, driving growth alongside NC-203 platform.
- U.S. federal shutdown hurt consumables sales; company exiting animal semen/beer/milk markets; investing heavily in software (20-25% of R&D) for platform expansion.
Last Updated: 09/11/2026, 09:45 AM
Read Full TranscriptEarnings
Latest Release
Sep 10, 2026
EPS / Forecast
-1.52 / -0.80
Revenue / Forecast
120M / 123.33M
Compare CHEMM to Peers and Sector
Metrics to compare | CHEMM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCHEMMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 43.5x | 13.4x | −0.4x | |
PEG Ratio | 2.80 | −0.35 | 0.00 | |
Price / Book | 12.1x | 1.4x | 2.6x | |
Price / LTM Sales | 17.2x | 2.1x | 3.0x | |
Upside (Analyst Target) | 24.1% | 2.0% | 54.5% | |
Fair Value Upside | Unlock | 5.1% | 7.0% | Unlock |
ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter NC-203, a high-precision cell counter designed to deliver complex cell samples; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the ChemoMetec (CHEMM) Stock Price Today?
The ChemoMetec stock price today is 510.00 DKK.
What Stock Exchange Does ChemoMetec Trade On?
ChemoMetec is listed and trades on the Copenhagen Stock Exchange.
What Is the Stock Symbol for ChemoMetec?
The stock symbol for ChemoMetec is "CHEMM."
Does ChemoMetec Pay Dividends? What’s The Current Dividend Yield?
The ChemoMetec dividend yield is 1.4%.
What Is the ChemoMetec Market Cap?
As of today, ChemoMetec market cap is 8.77B DKK.
What Is ChemoMetec's Earnings Per Share (TTM)?
The ChemoMetec EPS (TTM) is 11.60.
When Is the Next ChemoMetec Earnings Date?
ChemoMetec will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is CHEMM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has ChemoMetec Stock Split?
ChemoMetec has split 0 times.
How Many Employees Does ChemoMetec Have?
ChemoMetec has 174 employees.
What is the current trading status of ChemoMetec (CHEMM)?
As of Sep 19, 2026, ChemoMetec (CHEMM) is trading at a price of 510.00 DKK, with a previous close of 521.50 DKK. The stock has fluctuated within a day range of 504.00 DKK to 526.50 DKK, while its 52-week range spans from 235.20 DKK to 804.00 DKK.
What Is ChemoMetec (CHEMM) Price Target According to Analysts?
The average 12-month price target for ChemoMetec is 635.00 DKK, with a high estimate of 715 DKK and a low estimate of 550 DKK. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +24.51% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.